<DOC>
	<DOCNO>NCT02641769</DOCNO>
	<brief_summary>This open label , single arm , single center investigation ass safety efficacy purify adult autologous bone marrow derive CD34+ , CD133+ , mesenchymal stem cell inject seminiferous tubule testis , 12 week follow-up period . The investigator ' select model research base maximize efficiency approach choose autologous pattern preserve genetic make-up individual vital infertility condition . Additionally approach involves inject combination different purify cell type aid retrieval spermatogenesis , generation mature spermatozoon . Expected outcomes study defined general improvement infertile patient regard testicular morphology , sexual function , semen quality , development primary secondary spermatocyte , spermatid , mature spermatozoon testis , seminiferous tubule , semen .</brief_summary>
	<brief_title>Intra-Testicular Transplantation Autologous Stem Cells Treatment Non-Obstructive Azoospermia Male Infertility .</brief_title>
	<detailed_description>Non-obstructive azoospermia ( NOA ) generally consider non-medically manageable cause male infertility . These patient , constitute 10 % infertile men , abnormal spermatogenesis cause azoospermia . The etiology affect approximately 60 % azoospermic men , include non-obstructive cause azoospermia , include toxic exposure abnormal testicular development . NOA result either primary testicular failure ( elevated Luteinizing Hormone ( LH ) , Follicle stimulate hormone ( FSH ) , small testis affect 10 % men present infertility ) , secondary testicular failure ( congenital hypogonadotropic hypogonadism decrease LH FSH , small testis ) , incomplete ambiguous testicular failure ( either increase FSH normal volume testis , normal FSH small testis , normal FSH normal testis volume ) . Prior microsurgical testicular sperm retrieval technique IVF/ICSI , donor insemination option available men NOA . The establishment vitro fertilization use intracytoplasmic sperm injection ( ICSI ) standard treatment modality result number men successfully father child surgically retrieve sperm testis . The challenge , however , improve spermatogenic function enable appearance sperm ejaculate improve chance successful retrieval testis ICSI . The initial evaluation aim resolve follow issue : ( 1 ) confirm azoospermia , ( 2 ) differentiate obstructive non-obstructive etiology , ( 3 ) assess presence reversible factor ( 4 ) evaluate presence genetic abnormality . An elevated follicle-stimulating hormone ( FSH ) level absence normal spermatogenesis testicular histology presence azoospermia generally consider sufficient evidence non-obstructive etiology . The common reversible factor need rule include recent exogenous hormone administration , severe febrile illness , chemotherapy/radiation prolong antibiotic use . During past year considerable progress derivation male germ cell pluripotent stem cell make . These study provide desirable experimental model elucidate underlying molecular mechanism male germ cell development potential strategy produce haploid germ cell treatment male infertility . Spermatogenesis complex process spermatogonial stem cell ( SSC ) self-renew differentiate haploid spermatozoon . In mammal , process take place seminiferous tubule testis , provide functional niche male germ cell involve three major stage : mitosis , meiosis , spermiogenesis . Errors stage spermatogenesis result subfertility infertility . Researchers currently develop alternative treatment option men involve stem cell . It verify mouse induced pluripotent stem cell ( iPSCs ) form functional spermatozoon . Functional assay show spermatozoon generate iPSCs capable fertilizing oocyte intracytoplasmatic injection give rise fertile offspring follow embryo transfer . So far , functional male gamete human iPSCs obtain . There two possible approach generate male germ cell pluripotent stem cell : vitro differentiation advance , haploid cell product combine vitro differentiation vivo transplantation . However , originality study illustrate transplantation purify autologous CD34+/CD133+ mesenchymal bone marrow stem cell ( BMSCs ) infertile patient without vitro breeding , culture , manipulation thus avoid vitro cell propagation risk genetic mutation DNA change . The cell withdrawn inject back patient day procedure , hence confer high safety efficacy parameter .</detailed_description>
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Infertility , Male</mesh_term>
	<mesh_term>Azoospermia</mesh_term>
	<criteria>Infertile male confirm diagnosis nonobstructive azoospermia ( NOA ) Patients Obstructive Azoospermia ( OA ) Previous surgical history Testis Patients infectious genital disease Patients anatomical abnormality genital tract Patients major medical problem malignancy Chromosomal aberration ( e.g . Y microdeletion , trisomyâ€¦ . )</criteria>
	<gender>Male</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>